Navigation Links
American Oriental Bioengineering Reports Third Quarter 2011 Financial Results
Date:11/14/2011

JERSEY CITY, N.J., Nov. 14, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), (the "Company" or "AOB"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over-the-counter ("OTC") products, today announced financial results for the third quarter ended September 30, 2011.

2011 Third Quarter Financial ResultsTotal Revenue for the third quarter of 2011 was $53.9 million, compared to $91.5 million in the same period of 2010. We strategically shift the products mix, decreasing the manufacturing of certain generic drugs from lower margin products toward higher-margin products in order to minimize the impact from the increased cost of certain raw materials and the continuing government price cut on certain products.

  • Revenue from manufacturing business was $49.1 million for the third quarter of 2011, compared to $ 87.5 million in the same period of 2010.

  • Revenue from pharmaceutical products was $40.3 million in the third quarter of 2011, compared to $77.2 million in the same period of 2010.
  • Revenue from nutraceutical products was $8.8 million in the third quarter of 2011, compared to $10.3 million in the same period of 2010.

  • Revenue from distribution business was $4.9 million for the third quarter of 2011, compared to $4.1 million in the same period of 2010.

  • Gross profit for the third quarter of 2011 was $25.2 million, compared to $47.3 million in the same period of 2010. Gross margin for the third quarter of 2011 was 46.7%, compared to 51.7% in the same period of 2010. The margin pressure was mainly caused by the increased costs of certain raw materials and newly levied urban construction and maintenance tax and educational surcharge to foreign invested companies in China si
    '/>"/>

    SOURCE American Oriental Bioengineering, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. American Oriental Bioengineering to Hold Third Quarter 2011 Earnings Conference Call at 8:00 AM on November 15, 2011
    2. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
    3. Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
    4. Novation Applauds the IMS Institute for Healthcare Informatics for Calling Attention to the Drug Shortage Crisis Facing American Hospitals
    5. Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
    6. Telik Announces Telintra Clinical Presentations at the Annual Meeting of the American Society of Hematology
    7. LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
    8. American Oriental Bioengineering Delays Release of its Third Quarter 2011 Financial Results and Earnings Conference Call
    9. Adeona Senior Vice President of Research & Development to Present at American College of Nutrition Annual Meeting
    10. Masimo Awarded the American Association of Respiratory Cares 2011 Zenith Award
    11. Discovery Labs Releases New AFECTAIR™ Performance Data Presented at the American Association for Respiratory Care Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
    (Date:7/29/2015)... 2015 The U.S. Food and Drug Administration ... ReShape Integrated Dual Balloon System, that may help fill ... with obesity and one or more obesity-related conditions, according ... (ASMBS), the nation,s largest organization for bariatric surgeons. ... review the FDA has approved this new device for ...
    (Date:7/29/2015)... 29, 2015  Shareholder rights law firm Robbins ... officers and directors of AMAG Pharmaceuticals, Inc. (NASDAQGS: ... Pharmaceuticals operates as a specialty pharmaceutical company that ... care.  The company markets Makena, a hydroxyprogesterone caproate ... in women with a singleton pregnancy. ...
    Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2
    ... Sept. 22, 2011 Biodel Inc. (Nasdaq: BIOD ... Chief Executive Officer, will be presenting at the 6th Annual ... New York.  The presentation is scheduled for Tuesday, September 27, ... to the live webcast or a replay of the presentation, ...
    ... Sept. 22, 2011 Reportlinker.com announces that ... in its catalogue: Generic ... http://www.reportlinker.com/p0619265/Generic-Drugs-The-Global-Market--Focus-on-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... * An examination of the strategies employed ...
    Cached Medicine Technology:Generic Drugs: The Global Market--Focus on Europe 2Generic Drugs: The Global Market--Focus on Europe 3Generic Drugs: The Global Market--Focus on Europe 4Generic Drugs: The Global Market--Focus on Europe 5Generic Drugs: The Global Market--Focus on Europe 6Generic Drugs: The Global Market--Focus on Europe 7Generic Drugs: The Global Market--Focus on Europe 8Generic Drugs: The Global Market--Focus on Europe 9Generic Drugs: The Global Market--Focus on Europe 10
    (Date:7/30/2015)... ... 2015 , ... Summer is the dry eye season, especially in parts of ... dry and hot 2015 summer season and the dry eye rate in the hot ... discuss the 2015 summer season and identify the primary dry eye hot spots on ...
    (Date:7/30/2015)... ... July 30, 2015 , ... According to Chicago Implant ... a complete removable denture acceptable. The demand for dental implants is rising exponentially ... expensive, immediate loading techniques will have the ability to offer the patient a ...
    (Date:7/30/2015)... , ... July 30, 2015 , ... ... contract manufacturing and packaging services for consumer brands, recently completed a consolidation of ... Baltimore, MD. Previously, the company operated out of two separate locations situated 11 ...
    (Date:7/30/2015)... ... 2015 , ... Addictions Training Institute has announced the launch of ... and Substance Abuse Counselors. , "We are thrilled to be launching Addictions Training Institute,” ... of Alcohol and Drug Counselors nationwide. We are excited to be helping fill ...
    (Date:7/29/2015)... (PRWEB) , ... July 30, 2015 , ... ... available for their clients, BOC approved provider of online continuing education courses ... course offerings to their exclusive Andrews Research and Education Sports Medicine Series. , ...
    Breaking Medicine News(10 mins):Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3
    ... de Montréal and the Centre hospitalier de l’Université de ... the// human immunodeficiency virus (HIV). For the first time, ... to HIV and found a way to correct the ... biology, immunology, and virology, has confirmed the identification of ...
    ... epidemic proportions in Gujarat according to the government there ... any part of flood-ravaged Surat.// ,Quoting the ... State Health Secretary Amarjit Singh, Delhi, said that all ... rodent samples for plague as well as for Hantavirus ...
    ... emotional debate, US health authorities have approved the sale ... women 18 years and older.// ,But girls ... the Food and Drug Administration said Thursday. ... contained in birth control pills, interrupts pregnancy if used ...
    ... Scientists at the Indian Council of Agricultural Research (ICAR) have ... for diabetics because of its low caloric// content. ... blood can be developed from this new 'Dicoccum' variety of ... the Dharwad center of University of Agricultural Sciences developed the ...
    ... compound called rasfonin has been synthesized from a fungus for ... a New Zealand cave cave. //A chemical found in this ... harming healthy cells. ,"In 2000, scientists in Japan ... a prototype anticancer agent, but no one has been able ...
    ... in the center of attention now a days experts have ... actually be too fat //for their own good. ... coming from several top health groups, like the World Health ... the American Academy of Pediatrics as to if baby fat, ...
    Cached Medicine News:Health News:Researchers Make a Major Strategic Breakthrough in Controlling the AIDS Virus 2Health News:Cancer-Killing Compound From A Fungus 2Health News:Chubbiness In Babies Might Not Be A Cute Sign 2
    ...
    ... Retriever is for arthroscopic and open soft tissue ... complicated procedural steps. It may be used ... and in conjunction with,anchors or screws (including suture ... needle tip permits the placement of a variety ...
    The Nordt Knot Tightener allows both pushing and spreading of knots, reproducing identical techniques,used when tying traditional open knots. The Nordt Knot Tightener allows tying of any type of s...
    Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
    Medicine Products: